Article Information
History
- December 25, 2021.
Article Versions
- You are currently viewing Version 1 of this article (December 25, 2021 - 10:20).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nerea Martín Almazán1,2,3,*,
- Afsar Rahbar1,2,*,†,
- Marcus Carlsson4,
- Tove Hoffman5,
- Linda Kolstad5,
- Bengt Rönnberg5,
- Mattia Russel Pantalone1,2,
- Ilona Lewensohn Fuchs6,7,
- Anna Nauclér1,
- Mats Ohlin8,
- Mariusz Sacharczuk9,10,
- Piotr Religa1,2,10,
- Stefan Amér11,
- Christian Molnár11,12,
- Åke Lundkvist5,
- Andres Susrud13,
- Birger Sörensen13 and
- Cecilia Söderberg-Nauclér1,2,†
- 1Department of Medicine, Unit for Microbial Pathogenesis, Karolinska Institutet, Stockholm, Sweden
- 2Department of Neurology, Karolinska University Hospital, Stockholm, Sweden
- 3Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden
- 4Centre for the Mathematical Sciences, Lund University
- 5Zoonosis Science Center (ZSC), Department of Medical Biochemistry and Microbiology (IMBIM), Uppsala University, Uppsala, Sweden
- 6Division of Clinical Microbiology, Department of Labortory Medicine, Karolinska Institutet, Stockholm, Sweden
- 7Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
- 8Department of Immunotechnology and SciLifeLab Human Antibody Therapeutics Infrastructure Unit, Lund University, Lund, Sweden
- 9Faculty of Pharmacy with the Laboratory Medicine Division, Department of Pharmacodynamics, Medical University of Warsaw, Centre for Preclinical Research and Technology, Banacha 1B, Warsaw, Poland
- 10Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postępu 36A, Jastrzebiec, Poland
- 11Familjeläkarna Saltsjöbaden, Saltsjöbaden, Sweden
- 12Department of Neurobiology, Care Sciences and Society, NVS, Karolinska Institutet, Stockholm, Sweden
- 13Immunor AS, Oslo, Norway
- ↵†Corresponding authors: Email: cecilia.naucler{at}ki.se, afsar.rahbar{at}ki.se
↵* These authors contributed equally to this work.
Posted December 25, 2021.
Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics
